Swiss Life stock trades steady as higher fee income supports earnings
Published on 07/17/2026 at 20:18 | Editorial responsibility: Rafael MĂĽller, Editor-in-Chief AD HOC NEWS
Swiss Life Holding (ISIN CH0014852781) stock continues to reflect the group’s resilient earnings profile, supported by higher fee income and solid asset management flows alongside a disciplined capital position. According to the Swiss Life 2024 half-year report dated 14 August 2024, the company reported robust growth in its fee-based businesses, which now play a central role in its profitability mix.
Fee income rises 9.3 percent
In the first half of 2024, Swiss Life reported fee income of CHF 1.31 billion, an increase of 9.3% compared with CHF 1.20 billion in the first half of 2023, underscoring the strategic shift toward capital-light, fee-generating activities as highlighted in the company’s 2024 half-year results presentation available via the investor relations page at Swiss Life’s investors section. This growth in fee income reflects both the expansion of its commissioned business and higher assets under management in third-party mandates, which are sensitive to market levels but also benefit from net inflows.
Alongside fee income growth, Swiss Life reported adjusted profit attributable to shareholders of CHF 782 million for the first half of 2024, slightly above the CHF 770 million reported in the first half of 2023, according to the same half-year report available through the investor relations materials linked on the Swiss Life investors site. The modest year-on-year profit increase, despite a mixed capital-market backdrop and ongoing normalization of interest rates, illustrates the role of recurring fee income and asset management earnings in stabilizing the group’s overall profitability.
Asset management and premiums underpin scale
Premiums written and policy fees provide another dimension of scale for Swiss Life’s business. In the first half of 2024, the group stated that premium volume across its insurance operations remained broadly stable compared with the prior year period, at around CHF 12.0 billion on a gross basis according to figures summarized in its half-year documentation on the investors page. Stability in premium income, combined with the rising weight of fee-based revenues, indicates that Swiss Life is broadly maintaining its insurance franchise while increasingly extracting value from advisory and asset management services.
Swiss Life Asset Managers play a key role in the group’s earnings mix, managing both proprietary and third-party assets. As outlined in the half-year 2024 reporting accessible via the Swiss Life investors portal at Swiss Life investors, assets under management in third-party mandates amounted to roughly CHF 111 billion as of 30 June 2024, compared with CHF 106 billion a year earlier, reflecting net inflows and market performance. For investors, this increase in third-party assets under management is significant because it directly supports fee income and improves scalability without requiring equivalent balance-sheet deployment.
Capital strength remains a cornerstone of Swiss Life’s strategy, and regulatory solvency metrics help frame the risk profile. In its half-year 2024 report, the group indicated a Swiss Solvency Test (SST) ratio of around 215% as of 30 June 2024, compared with approximately 205% one year earlier, according to details discussed in the risk and capital section of the materials available through the investors site. The higher SST ratio provides buffer capacity for shareholder distributions and strategic investments, while also signaling resilience under regulatory stress scenarios.
Dividend stability and payout signals
Dividend policy is a key consideration for many holders of Swiss Life stock. For the 2023 financial year, Swiss Life’s annual report and general meeting documentation, which can be accessed through the investor relations hub at Swiss Life investors, show that the company proposed and paid a dividend of CHF 33 per share, up from CHF 30 per share for the 2022 financial year. This increase of CHF 3 per share represents a 10% year-on-year rise in the cash distribution, maintaining Swiss Life’s pattern of gradual dividend growth supported by earnings and capital strength.
From an investor perspective, the combination of a rising dividend and a robust SST ratio suggests that management is confident in the sustainability of its cash generation. At the same time, the company has continued to invest in its advisory and asset management platforms, aiming to deepen fee income while keeping balance sheet risk in check. The dividend progression, as evidenced by the CHF 30 to CHF 33 step between the 2022 and 2023 financial years, highlights Swiss Life’s emphasis on delivering capital returns while balancing regulatory and market constraints as detailed in its annual reporting materials linked via the investor relations page.
Swiss Life fundamentals behind the stock
Key metrics such as fee income growth, solvency, and dividend progression help explain the valuation of Swiss Life stock alongside broader insurance-market dynamics.
Life and pensions products
Swiss Life’s core offering revolves around life insurance and pensions solutions that combine long-term savings, risk coverage, and retirement planning. The group operates across several markets, including Switzerland, France, Germany, and international segments, where it provides individual life policies, group life and pensions, disability coverage, and other protection products. In the 2023 annual report, accessible via the investor relations site at Swiss Life investors, the company highlights that life insurance and pensions remain its largest revenue contributor, with significant embedded value stored in the in-force book and new business margins shaped by interest rates and regulatory frameworks.
Advisory services, including financial planning and retirement advice, complement the insurance product suite and contribute to fee income. By helping customers structure their retirement savings, optimize tax-advantaged products, and integrate risk coverage, Swiss Life deepens relationships and generates recurring commissions. For investors analyzing Swiss Life stock, the link between advisory-led sales and fee income growth is particularly important, because it demonstrates how product design and distribution model support the transition toward capital-light earnings, which are less sensitive to financial-market volatility than traditional guaranteed-life portfolios.
Swiss Life stock and market valuation
Swiss Life stock is listed on SIX Swiss Exchange, where shares trade in Swiss francs and reflect both the company’s insurance operations and its growing fee-based businesses. As of 30 June 2024, the group’s market capitalization stood at approximately CHF 16.5 billion according to a compilation of market data reported in financial portals and summarized alongside Swiss Life’s own investor-relations materials available via the investors page. This valuation reflects both current earnings and the market’s expectations regarding the sustainability of fee income and the stability of insurance profits.
The balance between insurance margins, asset management fees, and regulatory capital requirements shapes how Swiss Life stock trades relative to other European insurers and asset managers. Investors studying the stock often compare its price-to-earnings and price-to-book multiples with those of peers in the European life insurance and pensions space, while also monitoring the trajectory of the SST ratio and dividend. The increase in fee income by 9.3% year on year in the first half of 2024, combined with a 10% rise in the dividend per share between the 2022 and 2023 financial years and an SST ratio moving from around 205% to approximately 215%, offers a quantified picture of how earnings quality and capital strength have evolved over time, which is central to ongoing valuation discussions.
Swiss Life Holding key data
- Company: Swiss Life Holding Ltd.
- ISIN: CH0014852781
- Ticker: SIX: SLHN
- Trading venue: SIX Swiss Exchange
- Price (as of 30 June 2024, 16:30 CET): CHF 612.00 CHF
- Market capitalization: CHF 16.5 billion CHF (as of 30 June 2024)
- Sector / Industry: Financials / Life & Health Insurance
- Index membership: SMI
- Next earnings date: 14 March 2025
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
